Group items tagged

Prevalence of vitamin d insufficiency in patients with Parkinson disease and Alzheimer disease.\nEvatt ML, Delong MR, Khazai N, Rosen A, Triche S, Tangpricha V.\nArch Neurol. 2008 Oct;65(10):1348-52.\nPMID: 18852350

Plasma Phosphatidylcholine Docosahexaenoic Acid Content and Risk of Dementia and Alzheimer Disease: The Framingham Heart StudyErnst J. Schaefer, Vanina Bongard, Alexa S. Beiser, Stefania Lamon-Fava, Sander J. Robins, Rhoda Au, Katherine L. Tucker, David

Phospholipase A(2) activation as a therapeutic approach for cognitive enhancement in early-stage Alzheimer disease. Schaeffer EL, Forlenza OV, Gattaz WF. Psychopharmacology (Berl). 2009 Jan;202(1-3):37-51. Epub 2008 Oct 14. PMID: 18853146 DOI: 10.1007/s00213-008-1351-0

Phospholipase A(2) activation as a therapeutic approach for cognitive enhancement in early-stage Alzheimer disease. Schaeffer EL, Forlenza OV, Gattaz WF. Psychopharmacology (Berl). 2009 Jan;202(1-3):37-51. Epub 2008 Oct 14. PMID: 18853146 DOI: 10.1007/s00213-008-1351-0

Michael Mullan, CEO and President of the Roskamp Institute and researcher of Alzheimer Disease Sarasota, FL - 34243.

Michael Mullan, CEO and President of the Roskamp Institute, Sarasota, FL. He is a biomedical researcher of the beta amyloid protein and its relation to Alzheime.

Michael Mullan, CEO and President of the Roskamp Institute, Sarasota, FL. He is a leading expert in alzheimers research and other neurodegnerative disorder.

This video has indicating how you can reduce the risk of Alzheimer Disease by taking proper diets. Check details here: http://www.michaelmullan.org/

Michael Mullan, CEO and President of the Roskamp Institute, Sarasota, FL. He research to cure Alzheimer's Disease. He discovered Swedish Mutation in the Amyloid Precursor Protein gene that is widely used in Alzheimer's research today. Michael Mullan is a leading expert in Alzheimers Research and other neurodegnerative disorder.

"High blood levels of leptin, a hormone that regulates appetite, may guard against Alzheimer's disease, new research suggests. "Hopefully, in 10 or 15 years this may be one of many agents that we use to reduce the risk of Alzheimer's disease," said senior study author Dr. Sudha Seshadri, an associate professor of neurology at Boston University School of Medicine. "Or it may be one of many markers that we measure in combination to predict risk." But many more studies of different population groups are needed to determine whether leptin can play such a pivotal role in predicting the risk of Alzheimer's, Seshadri said. The research, which was reported in the Dec. 16 issue of the Journal of the American Medical Association, was done because "there has been some data relating body weight to the risk of Alzheimer's disease," Seshadri said. "When we looked at animal studies, we found some data to indicate that leptin not only produces a feeling of satiety but also has a beneficial effect on the hippocampus. It was important to see if that was true in humans." The hippocampus is a portion of the brain that plays a role in important aspects of memory."

Alzheimer's is a mental illness that mostly affects the elderly. It is characterized by dementia, cognitive impairment, and mood swings. The patient gradually fades into a state of perpetual darkness and lack of self-awareness. Here are some steps we can take to reduce our own risk.

Scientists are trying to find ways to prevent Alzheimer's before it comes knocking at your doorstep. Extensive research is taking place even as you read this. Everyone hopes to put together the answer before it becomes a global issue. Here are a few risk factors that you can and can't avoid:

People in Asia have been eating fermented foods for more than 1,000 years. One vegan fermented food, renowned in Asia for its ability to protect against heart attacks, was recently shown to have a powerful ability in lab experiments to prevent formation of the clumps of tangled protein involved in Alzheimer's disease. if this works as well in the human brain as scientists expect, it will be a great addition to the tables of anyone who is concerned about this terrible disease

Amyloid-degrading ability of nattokinase from Bacillus subtilis natto. Hsu RL, Lee KT, Wang JH, Lee LY, Chen RP. J Agric Food Chem. 2009 Jan 28;57(2):503-8. PMID: 19117402 DOI: 10.1021/jf803072r\n

ScienceDaily (Feb. 20, 2009) - A vegan food renowned in Asia for its ability to protect against heart attacks also shows a powerful ability in lab experiments to prevent formation of the clumps of tangled protein involved in Alzheimer's disease, scientists in Taiwan are reporting. \n\nRita P. Y. Chen and colleagues point out that people in Asia have been eating natto - a fermented food made from boiled soybeans -for more than 1,000 years. Natto contains an enzyme, nattokinase, that has effects similar to clot-busting drugs used in heart disease.Nattokinase is sold a dietary supplement to impro 

Spice Healer An ingredient in curry shows promise for treating Alzheimer's, cancer and other diseases By Gary Stix. Scientific American, February 2007.

Perls TT. The different paths to 100. Am J Clin Nutr. 2006 Feb;83(2):484S-487S. Review. PMID: 16470017 [PubMed - indexed for MEDLINE]

A multi-institutional team of researchers led by Emory University has defined for the first time how metal ions bind to amyloid fibrils in the brain in a way that appears toxic to neurons. Amyloid fibrils are linked to the development of neurodegenerative